Joseph Bateman

Professor of Molecular Neuroscience at King's College London. Studying the molecular basis of neurological disease. All things mitochondria and mTOR.

[Institute of Psychiatry, Psychology & Neuroscience @KingsIoPPN]

The #mTOR node symposium brought together researchers, clinicians, people with lived experience and industry partners to discuss research and collaboration within the community.

https://t.co/n18UZhAouP

@BatemanLab @RDRUKHub @UKTSA @PTENResearch @The_MRC
#RareDiseaseReseach

[Rare Disease Research UK @RDRUKHub]

Did you know?

Around 80% of rare conditions arise due to changes in a person's genomic makeup, which can be inherited or arise for the first time in an individual. 🧬

🎙️Hear from mTOR node

@BatemanLab

[Joseph Bateman @BatemanLab]

I am looking for a Research Assistant for a 10 month position in my lab. The RA will support several ongoing projects primarily using Drosophila models but also iPSC/organoid models of rare disease. @KingsIoPPN
https://t.co/JtPQuqHhss

[Joseph Bateman @BatemanLab]

Great to see this published and thanks to all 42 co-authors! Including @SilaUltanir @jansen_ac @palneurolab @UKTSA @CellsigL

[Rare Disease Research UK @RDRUKHub]

🚀Check out this recent publication from the mTOR Pathway Diseases node - Challenges and opportunities from bench to bedside and the mTOR node https://t.co/K3diRJ1oS5
@BatemanLab @CharlotteRTye

[Efeyan Lab @EfeyanLab]

MSCA International Training Program MENTOR, European PhD Network focused on mTOR pathophysiology. Apply to one of the 18 open PhD positions!

[Joseph Bateman @BatemanLab]

Great to be collaborating on this! @KingsIoPPN @RDRUKHub

[MaxWell Biosystems @mxwbio]

We’re delighted to announce a new partnership between Oxford StemTech, @KingsCollegeLon, and MaxWell Biosystems, funded by @Innosuisse.

Many patients with #epilepsy struggle with limited treatment options to manage their seizures effectively. To address this, our collaboration is focused on creating a high-throughput #drugtesting platform using physiologically relevant models.

King’s will provide access to epilepsy patients. By integrating Oxford StemTech’s ReproPlex #iPSC reprogramming technology with MaxWell Biosystems’ advanced MaxTwo HD-#MEA (High-Density Microelectrode Array) System featuring a 24-well plate format, we can simultaneously analyze multiple patient-specific brain assembloids. This approach will provide a unique platform to understand epilepsy better and test potential new treatments with precision.

We are excited to work together on this project and look forward to contributing to advancements in epilepsy research. Please refer to our website for more details 👉https://t.co/o7Hb4vJ5tv
Stay tuned for updates!

[Institute of Psychiatry, Psychology & Neuroscience @KingsIoPPN]

👏🧠A new partnership between @KingsCollegeLon (@BatemanLab) , OxfordStemTech and @mxwbio has received funding from @InnovateUK to create a high-throughput drug testing platform to address limited treatment options for epilepsy
#PrecisionMedicine #iPSC #organoids #Neuroscience

[Rare Disease Research UK @RDRUKHub]

🧲Ready to make a real difference in research and advocacy?
📡By listening, sharing, and working together, we can better address the challenges faced in rare disease research
🌟Join us for our free webinar on Introduction to Co-Production!

Register now🔗https://t.co/84qKALuN2i

[Rare Disease Research UK @RDRUKHub]

📢Registrations Now Open📢

🌟Join us for our 2nd Hybrid Annual Conference!🌟

💊inspiring keynote speakers 🪩lively panel discussions💥connect with others who are just as passionate about driving progress in rare disease research!

🔗https://t.co/9bdcgwvPh6

[Ram Chakrabarty @RPC_3312]

Our lab's latest study, spearheaded by a fantastic colleague, Colleen, reveals that the blood glucose-lowering effect of metformin requires the inhibition of mitochondrial ETC complex I. https://t.co/iDMQNNiZOM.

An insightful focus by Prof. Doug Green: https://t.co/U2p4pNtMgB

[Tuberous Sclerosis Association @UKTSA]

We had a brilliant time attending the mTOR Pathway Diseases node patient organisation workshop last week. Great to hear exciting updates from the #Research team and a great opportunity to connect with other patient orgs @BatemanLab @CharlotteRTye

[Charlotte Tye @CharlotteRTye]

A snippet from our day. I feel privileged to lead #PPI for the mTOR node and to learn so much from our patient organisation partners and lived experience experts- thank you for giving your time and helping our research grow. Watch this space! @KingsIoPPN

[Joseph Bateman @BatemanLab]

The excellent @CharlotteRTye led our mTOR Pathway Diseases node patient organisation workshop last week. Thanks to everyone that attended
@UKTSA @GoPI3Ks @ptenuki @LAMAction @myrovlytis @ChildGrowthUK
@EpilepsyInst @OrigamiCells.
Supported by @The_MRC @NIHRresearch @RDRUKHub

[Niccoli Lab @NiccoliLab]

We have funding from the MND Association for a PhD studentship, starting in September 2025, if interested please see
@FindAPhD
https://t.co/MGctGknjKY

[EpiGenRare - Rare Disease Research UK @EpiGenRare]

📢REGISTRATION NOW OPEN📢

🚨1st EpiGenRare Conference
🗓️26 March 2025
🏢Hyatt Regency, Manchester

Please register your attendance for free using the link or QR code below

https://t.co/7ZRJrkad6W

@smbanka @RDRUKHub

#RareDisease #rarediseaseresearch

[Joseph Bateman @BatemanLab]

It was a pleasure! Thanks for the invitation and stimulating discussions.

[Manchester Rare Conditions Centre @mft_iMRare]

A huge thank you to @BatemanLab from King's College London, who gave a fantastic seminar on the 'Mechanistic insight into the role of mTOR signalling in rare neurological diseases' today as part of our lunchtime seminar series.

[Aishwarya Acharya @acharyaish]

Incredibly excited to see our recent paper about the auto-regulation of #mTOR at #lysosomes featured on the cover of @MolecularCell 🤩🌍🎈 @DemetriadesLab

Huge thanks to @sahola6 for so beautifully capturing the essence of our story in her artwork😍

👉🏼https://t.co/DWf3i0090f

[Joseph Bateman @BatemanLab]

Application deadline for this is tomorrow!

[Joseph Bateman @BatemanLab]

Interested in researching neurodevelopmental disorders using iPSCs? Take a look at our iCASE PhD studentship, together with @NCNDgroup_KCL, to study mTORopathies https://t.co/XIMyxYXLBu
@KCL_MRCDTP @KingsIoPPN
https://t.co/fXs7EPU6u0

[KCL MRC DTP @KCL_MRCDTP]

Meet iCASE student Mohua! Whilst you hear about what Mohua is researching, this is your reminder that applications for 2025 entry MRC DTP Studentships @KingsCollegeLon will close tomorrow at 13:00 GMT. Have you thought about applying yet?

#MRCDTP25